Arkolith/Insider Trading/NLTX/Form 4

Baker Bros. Advisors (GP) LLC

Director, 10% OwnerNeoleukin Therapeutics, Inc. (NLTX) · full profile →Form 4 · filed Oct 10, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 5, 2023Option exercise(X)536K——1.7M
Oct 5, 2023Option exercise(X)57K——156K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 5, 2023Option exercise(X)57K—$0183K
Oct 5, 2023Option exercise(X)536K—$01.5M

Transaction Codes

X
Exercise of in-the-money derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-052526) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML